Monday, November 25, 2024
HomeTagsRP-A501

RP-A501

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease

Rocket Pharmaceuticals, Inc, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics